iShares Healthcare Innovation UCITS ETF

The iShares Healthcare Innovation ETF is primarily paired with broad-market global equity trackers like SPYY and VWCE, which typically form the core of these portfolios at allocations between 47 and 70 percent. Complementary assets often include sector-specific growth plays such as technology, semiconductors, and communication services, alongside smaller tactical positions in emerging markets or precious metals like gold. This structure suggests that 2B78 serves as a thematic satellite holding, providing exposure to high-growth medical innovation while the core equity ETFs mitigate the volatility inherent in such a concentrated sector bet.

EuroFolio members utilize 2B78 as a surgical growth tilt rather than a foundational anchor, with allocations consistently ranging from 5 to 10 percent of total portfolio weight. High-performing portfolios like MaxSharpe and Mana demonstrate that investors are comfortable using this asset to capture industry-specific upside within a broader growth-oriented framework. By capping the exposure at this level, users maintain a diversified risk profile that benefits from the long-term demographic and technological tailwinds of the healthcare sector without exposing the entire portfolio to the specific drawdown risks associated with medical innovation cycles.